2,185
Views
55
CrossRef citations to date
0
Altmetric
Research Paper

Blood volatile compounds as biomarkers for colorectal cancer

, , , , , , , , , , , , , , , & show all
Pages 200-206 | Received 23 Jul 2013, Accepted 06 Oct 2013, Published online: 01 Nov 2013

References

  • Kim HJ, Yu MH, Kim H, Byun J, Lee C. Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 2008; 41:685 - 92; http://dx.doi.org/10.5483/BMBRep.2008.41.10.685; PMID: 18959813
  • Bingham S, Riboli E. Diet and cancer--the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 2004; 4:206 - 15; http://dx.doi.org/10.1038/nrc1298; PMID: 14993902
  • Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62:220 - 41; http://dx.doi.org/10.3322/caac.21149; PMID: 22700443
  • Montrose DC, Zhou XK, Kopelovich L, Yantiss RK, Karoly ED, Subbaramaiah K, Dannenberg AJ. Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia. Cancer Prev Res (Phila) 2012; 5:1358 - 67; http://dx.doi.org/10.1158/1940-6207.CAPR-12-0160; PMID: 22961778
  • Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343:1603 - 7; http://dx.doi.org/10.1056/NEJM200011303432203; PMID: 11096167
  • Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, et al, The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329:1977 - 81; http://dx.doi.org/10.1056/NEJM199312303292701; PMID: 8247072
  • Qiu Y, Cai G, Su M, Chen T, Liu Y, Xu Y, Ni Y, Zhao A, Cai S, Xu LX, et al. Urinary metabonomic study on colorectal cancer. J Proteome Res 2010; 9:1627 - 34; http://dx.doi.org/10.1021/pr901081y; PMID: 20121166
  • Nishiumi S, Kobayashi T, Ikeda A, Yoshie T, Kibi M, Izumi Y, Okuno T, Hayashi N, Kawano S, Takenawa T, et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One 2012; 7:e40459; http://dx.doi.org/10.1371/journal.pone.0040459; PMID: 22792336
  • Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986; 104:66 - 73; http://dx.doi.org/10.7326/0003-4819-104-1-66; PMID: 3510056
  • Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348:1467 - 71; http://dx.doi.org/10.1016/S0140-6736(96)03430-7; PMID: 8942774
  • Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Gleeson K, Greenberg J, Maxfield RA, Rom WN. Detection of lung cancer with volatile markers in the breath. Chest 2003; 123:2115 - 23; http://dx.doi.org/10.1378/chest.123.6.2115; PMID: 12796197
  • Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O’Neill HJ. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem 1985; 31:1278 - 82; PMID: 4017231
  • Hietanen E, Bartsch H, Béréziat JC, Camus AM, McClinton S, Eremin O, Davidson L, Boyle P. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr 1994; 48:575 - 86; PMID: 7957003
  • Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, Gunawardena R, Kwon CS, Rahbari-Oskoui F, Wong C. Volatile markers of breast cancer in the breath. Breast J 2003; 9:184 - 91; http://dx.doi.org/10.1046/j.1524-4741.2003.09309.x; PMID: 12752626
  • Altomare DF, Di Lena M, Porcelli F, Trizio L, Travaglio E, Tutino M, Dragonieri S, Memeo V, de Gennaro G. Exhaled volatile organic compounds identify patients with colorectal cancer. Br J Surg 2013; 100:144 - 50; http://dx.doi.org/10.1002/bjs.8942; PMID: 23212621
  • Gordon SM, Wallace LA, Brinkman MC, Callahan PJ, Kenny DV. Volatile organic compounds as breath biomarkers for active and passive smoking. Environ Health Perspect 2002; 110:689 - 98; http://dx.doi.org/10.1289/ehp.02110689; PMID: 12117646
  • Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res 2007; 6:469 - 79; http://dx.doi.org/10.1021/pr060594q; PMID: 17269704
  • Wiklund S, Johansson E, Sjöström L, Mellerowicz EJ, Edlund U, Shockcor JP, Gottfries J, Moritz T, Trygg J. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 2008; 80:115 - 22; http://dx.doi.org/10.1021/ac0713510; PMID: 18027910
  • Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis--focus on volatile organic compounds. Clin Chim Acta 2004; 347:25 - 39; http://dx.doi.org/10.1016/j.cccn.2004.04.023; PMID: 15313139
  • Pasikanti KK, Esuvaranathan K, Ho PC, Mahendran R, Kamaraj R, Wu QH, Chiong E, Chan EC. Noninvasive urinary metabonomic diagnosis of human bladder cancer. J Proteome Res 2010; 9:2988 - 95; http://dx.doi.org/10.1021/pr901173v; PMID: 20337499
  • Chen JL, Fan J, Yan LS, Guo HQ, Xiong JJ, Ren Y, Hu JD. Urine Metabolite Profiling of Human Colorectal Cancer by Capillary Electrophoresis Mass Spectrometry Based on MRB. Gastroenterol Res Pract 2012; 2012:125890; http://dx.doi.org/10.1155/2012/125890; PMID: 23243419
  • Barash O, Peled N, Tisch U, Bunn PA Jr., Hirsch FR, Haick H. Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine 2012; 8:580 - 9; http://dx.doi.org/10.1016/j.nano.2011.10.001; PMID: 22033081
  • Chen X, Xu F, Wang Y, Pan Y, Lu D, Wang P, Ying K, Chen E, Zhang W. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer 2007; 110:835 - 44; http://dx.doi.org/10.1002/cncr.22844; PMID: 17599760
  • Mal M, Koh PK, Cheah PY, Chan EC. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry. Anal Bioanal Chem 2012; 403:483 - 93; http://dx.doi.org/10.1007/s00216-012-5870-5; PMID: 22374317
  • Hu JD, Tang HQ, Zhang Q, Fan J, Hong J, Gu JZ, Chen JL. Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS. World J Gastroenterol 2011; 17:727 - 34; http://dx.doi.org/10.3748/wjg.v17.i6.727; PMID: 21390142
  • Nevedomskaya E, Ramautar R, Derks R, Westbroek I, Zondag G, van der Pluijm I, Deelder AM, Mayboroda OA. CE-MS for metabolic profiling of volume-limited urine samples: application to accelerated aging TTD mice. J Proteome Res 2010; 9:4869 - 74; http://dx.doi.org/10.1021/pr100634d; PMID: 20690666
  • Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, et al, RISC Study Group. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 2010; 5:e10883; http://dx.doi.org/10.1371/journal.pone.0010883; PMID: 20526369
  • Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, Tisch U, Haick H. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 2010; 103:542 - 51; http://dx.doi.org/10.1038/sj.bjc.6605810; PMID: 20648015
  • Knight JA. Free radicals: their history and current status in aging and disease. Ann Clin Lab Sci 1998; 28:331 - 46; PMID: 9846200
  • Skrzydlewska E, Kozuszko B, Sulkowska M, Bogdan Z, Kozlowski M, Snarska J, Puchalski Z, Sulkowski S, Skrzydlewski Z. Antioxidant potential in esophageal, stomach and colorectal cancers. Hepatogastroenterology 2003; 50:126 - 31; PMID: 12630007
  • Terry P, Lagergren J, Ye W, Nyrén O, Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 2000; 87:750 - 4; http://dx.doi.org/10.1002/1097-0215(20000901)87:5<750::AID-IJC19>3.0.CO;2-6; PMID: 10925371
  • Polat MF, Taysi S, Gul M, Cikman O, Yilmaz I, Bakan E, Erdogan F. Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Funct 2002; 20:327 - 31; http://dx.doi.org/10.1002/cbf.980; PMID: 12415567
  • Choi MA, Kim BS, Yu R. Serum antioxidative vitamin levels and lipid peroxidation in gastric carcinoma patients. Cancer Lett 1999; 136:89 - 93; http://dx.doi.org/10.1016/S0304-3835(98)00312-7; PMID: 10211945
  • Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, Gumus M. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 2002; 32:162 - 6; http://dx.doi.org/10.1093/jjco/hyf035; PMID: 12110642
  • Abaffy T, Duncan R, Riemer DD, Tietje O, Elgart G, Milikowski C, DeFazio RA. Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process. PLoS One 2010; 5:e13813; http://dx.doi.org/10.1371/journal.pone.0013813; PMID: 21079799
  • Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295 - 304; http://dx.doi.org/10.1038/nrg2540; PMID: 19308066
  • De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X, Nelson WG. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res 1999; 59:3855 - 60; PMID: 10463569
  • Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999; 27:2291 - 8; http://dx.doi.org/10.1093/nar/27.11.2291; PMID: 10325416
  • Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP. The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) 2012; 5:992 - 1006; http://dx.doi.org/10.1158/1940-6207.CAPR-11-0441; PMID: 22689914
  • Filipiak W, Sponring A, Mikoviny T, Ager C, Schubert J, Miekisch W, Amann A, Troppmair J. Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro. Cancer Cell Int 2008; 8:17; http://dx.doi.org/10.1186/1475-2867-8-17; PMID: 19025629
  • Lin HM, Edmunds SI, Helsby NA, Ferguson LR, Rowan DD. Nontargeted urinary metabolite profiling of a mouse model of Crohn’s disease. J Proteome Res 2009; 8:2045 - 57; http://dx.doi.org/10.1021/pr800999t; PMID: 19275240
  • Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, Jia W, Sebedio JL. Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem 2009; 393:163 - 75; http://dx.doi.org/10.1016/j.ab.2009.06.036; PMID: 19573517

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.